U.S. Stent Market Taking Dive ; Makers Try to Resolve Safety Fears

Summary

---

BOSTON Drug-oozing heart stents became the fastest-selling medical device in modern history and a cash cow for New Brunswick- based Johnson & Johnson and Boston Scientific Corp. because of the device's ability to prevent scar tissue from forming new blockages after artery-clearing surgery.

But safety questions about the stents have triggered steep sales declines and job cuts for the makers, and are expected to shrink the U.S. market by one-third this year a $1 billion drop just four years after the tiny gizmos were introduced.

See the full content of this document

Extract

---

U.S. Stent Market Taking Dive ; Makers Try to Resolve Safety Fears

J&J is cutting nearly 5,000 jobs due in part to a stent decline after studies questioned the devices' safety and effectiveness in preventing heart attacks and bypass surgery. Bo...

See the full content of this document

---